Citizens & Northern Corp Buys New Shares in iShares Biotechnology ETF (NASDAQ:IBB)

Citizens & Northern Corp purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,084 shares of the financial services provider’s stock, valued at approximately $276,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $30,000. HHM Wealth Advisors LLC grew its holdings in shares of iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the last quarter. Newbridge Financial Services Group Inc. purchased a new position in iShares Biotechnology ETF in the 4th quarter worth $33,000. Finally, Hager Investment Management Services LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter worth $34,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.4 %

Shares of NASDAQ:IBB opened at $136.55 on Tuesday. The stock’s 50-day moving average price is $135.62 and its 200-day moving average price is $140.86. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.